PerkinElmer Operating Income 2011-2026 | PKI

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income PerkinElmer

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
357 M	347 M	301 M	1.26 B	196 M	-	362 M	324 M	296 M	251 M	-	165 M	228 M	103 M	158 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.26 B	103 M	334 M

Quarterly Operating Income PerkinElmer

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
81.9 M	90.8 M	72.2 M	-	98.2 M	85.7 M	44.1 M	-	69.2 M	78.1 M	76.1 M	-	111 M	232 M	262 M	510 M	196 M	332 M	468 M	-	248 M	176 M	44.7 M	138 M	78.7 M	91.7 M	53.3 M	116 M	80.2 M	88.1 M	39.9 M	93.6 M	78 M	74.2 M	49.8 M	77.2 M	75.8 M	66.3 M	60.6 M	-	67.4 M	59.5 M	46.8 M	30.6 M	58.8 M	69.6 M	51.8 M	92.9 M	58 M	40.2 M	36.7 M	-30.8 M	43.2 M	49.8 M	36.4 M	48.8 M	36.1 M	39.4 M	41.4 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
510 M	-30.8 M	100 M

Operating Income of other stocks in the Diagnostics research industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-46 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.35 B	$ 115.55	1.0 %	$ 35.1 B	USA
Akumin AKU	-28.1 M	-	-17.87 %	$ 25.9 M	Canada
Accelerate Diagnostics AXDX	-14 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	-7.91 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-32 M	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	-23.6 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-25.9 M	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	-50.2 M	$ 1.67	-2.34 %	$ 2.22 M	USA
CareDx, Inc CDNA	-30.8 M	$ 21.23	5.83 %	$ 1.13 B	USA
Castle Biosciences CSTL	8.67 M	$ 24.46	3.25 %	$ 679 M	USA
DermTech DMTK	-104 M	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	-12.4 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	-206 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	-73.9 M	$ 16.31	1.75 %	$ 493 M	USA
Global Cord Blood Corporation CO	609 M	-	-	$ 399 M	China
Genetron Holdings Limited GTH	-518 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	25.2 M	$ 169.8	1.23 %	$ 8.42 B	USA
Illumina ILMN	-833 M	$ 127.88	1.95 %	$ 20.3 B	USA
Guardant Health GH	-437 M	$ 88.91	1.18 %	$ 11.1 B	USA
HTG Molecular Diagnostics HTGM	-20.8 M	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	-20.3 M	-	-	$ 1.31 B	USA
Lantheus Holdings LNTH	311 M	$ 84.33	1.82 %	$ 5.69 B	USA
Interpace Biosciences IDXG	4.08 M	$ 1.98	-2.37 %	$ 8.76 M	USA
Medpace Holdings MEDP	535 M	$ 410.54	4.35 %	$ 11.8 B	USA
Koninklijke Philips N.V. PHG	553 M	$ 27.47	-0.58 %	$ 20 B	Niderland
Motus GI Holdings MOTS	-11.9 M	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	466 M	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	-1.06 B	$ 9.54	2.03 %	$ 2.07 B	USA
Biomerica BMRA	-5.14 M	$ 2.14	-0.47 %	$ 4.92 M	USA
National Research Corporation NRC	22.6 M	$ 17.23	-0.12 %	$ 386 M	USA
ICON Public Limited Company ICLR	1.1 B	$ 102.17	-3.92 %	$ 8.43 B	Irlanda
Laboratory Corporation of America Holdings LH	1.38 B	$ 263.8	-0.43 %	$ 21.9 B	USA
Celcuity CELC	-172 M	$ 121.03	6.58 %	$ 5.66 B	USA
OpGen OPGN	325 K	-	-16.95 %	$ 1.54 M	USA
NeoGenomics NEO	-116 M	$ 8.29	4.8 %	$ 1.06 B	USA
Myriad Genetics MYGN	-387 M	$ 4.78	-0.21 %	$ 443 M	USA
Natera NTRA	-541 M	$ 203.75	1.3 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	1.56 B	$ 196.27	-1.66 %	$ 21.8 B	USA
Invitae Corporation NVTA	-94.9 M	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	-12.6 M	-	-2.3 %	$ 19.4 M	USA
Precipio PRPO	-1.2 M	$ 28.0	3.57 %	$ 44.9 M	USA
Personalis PSNL	-68.3 M	$ 6.1	3.39 %	$ 361 M	USA
Burning Rock Biotech Limited BNR	-797 M	$ 20.69	0.49 %	$ 223 M	China
Pacific Biosciences of California PACB	-554 M	$ 1.56	-0.64 %	$ 468 M	USA